Significant presence of CRT in the membrane of dying A2058 cells also occurred with doxorubicin (2) (about 90% of the whole population) and lepadin A (1) (about 40% of the whole population), which is in agreement with the translocation of the protein in an early phase of the anti-cancer mechanism. The gene discussed is CALR; the disease is cancer.